GENEDX HOLDINGS CORP (WGS) Stock News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of GeneDx Holdings Corp ("GeneDx" or the "Company") (NASDAQ: WGS). Such investors...

Top Biotech GeneDx Catapults 42% After Obliterating Earnings Forecasts

GeneDx stock catapulted more than 40% on Tuesday after the top-notch biotech smashed fourth-quarter expectations.

Crude Oil Gains 1.5%; Fluor Shares Plunge Following Downbeat Earnings

Mentions: SMCI FLR PRFX PTPI ...

Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday

Mentions: HEES INTC SMCI WSO ...

GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025

GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients

Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year

GeneDx to Participate in 45th Annual TD Cowen Health Care Conference

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of GeneDx Holdings Corp ("GeneDx" or the "Company") (NASDAQ: WGS). Such investors...

GeneDx Integrates with Epic, Enabling Broad Adoption of Genome and Exome Sequencing for Health Systems to Inform Patient Diagnosis and Accelerate Treatment

GeneDx to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 18, 2025

GeneDx: Even After Up 2,700% in 2024, Upside Is Still in Play

Saying shares of GeneDx skyrocketed in 2024 may be an understatement. As a leader in its market, upside is still a legitimate possibility for this name.

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GeneDx Announces Preliminary 2024 Financial Results

GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers

GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients

IBD 50's GeneDx Surges On FDA Recommendations For AI Device Development

GeneDx provides whole and exome gene sequencing to identify rare diseases.

Meta Stock, Energy Plays Lead Five Leaders Rebounding Bullishly

Energy plays, a biotech and a brokerage also are flashing buy signals or setting up.

Mentions: KNTK TLN IBKR META ...

GeneDx Strengthens Executive Leadership Team with Bryan Dechairo Named Chief Operating Officer

GeneDx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners

GeneDx to Participate in Upcoming Investor Conference

GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover

GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary